Group One Trading’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $70.8K | Sell |
41,900
-62,600
| -60% | -$129K | ﹤0.01% | 5003 |
|
|
2025
Q4 | $207K | Buy |
104,500
+19,500
| +23% | +$62.4K | ﹤0.01% | 4341 |
|
|
2025
Q3 | $247K | Buy |
85,000
+1,500
| +2% | +$3.45K | ﹤0.01% | 4441 |
|
|
2025
Q2 | $151K | Sell |
83,500
-29,000
| -26% | -$51.6K | ﹤0.01% | 4607 |
|
|
2025
Q1 | $169K | Sell |
112,500
-667,900
| -86% | -$1.69M | ﹤0.01% | 4160 |
|
|
2024
Q4 | $1.84M | Sell |
780,400
-234,900
| -23% | -$4.13M | ﹤0.01% | 1991 |
|
|
2024
Q3 | $29.9M | Buy |
1,015,300
+897,400
| +761% | +$20.7M | 0.09% | 181 |
|
|
2024
Q2 | $1.46M | Sell |
117,900
-64,900
| -36% | -$1.37M | 0.01% | 1703 |
|
|
2024
Q1 | $3.71M | Sell |
182,800
-116,300
| -39% | -$2.68M | 0.01% | 1028 |
|
|
2023
Q4 | $6.73M | Buy |
299,100
+236,500
| +378% | +$5M | 0.02% | 926 |
|
|
2023
Q3 | $1.04M | Sell |
62,600
-12,300
| -16% | -$244K | ﹤0.01% | 2225 |
|
|
2023
Q2 | $1.84M | Buy |
74,900
+27,200
| +57% | +$655K | 0.01% | 1783 |
|
|
2023
Q1 | $1.15M | Sell |
47,700
-471,900
| -91% | -$13.1M | ﹤0.01% | 2016 |
|
|
2022
Q4 | $15.3M | Sell |
519,600
-64,500
| -11% | -$2.32M | 0.04% | 512 |
|
|
2022
Q3 | $24.4M | Buy |
584,100
+2,600
| +0.4% | +$70.2K | 0.05% | 312 |
|
|
2022
Q2 | $16.4M | Buy |
581,500
+233,100
| +67% | +$5.89M | 0.03% | 569 |
|
|
2022
Q1 | $12.9M | Sell |
348,400
-17,400
| -5% | -$737K | 0.01% | 845 |
|
|
2021
Q4 | $16M | Sell |
365,800
-98,100
| -21% | -$5.14M | 0.01% | 789 |
|
|
2021
Q3 | $28.8M | Buy |
463,900
+252,500
| +119% | +$21.1M | 0.03% | 450 |
|
|
2021
Q2 | $18.1M | Buy |
211,400
+70,400
| +50% | +$3.77M | 0.02% | 694 |
|
|
2021
Q1 | $6.34M | Buy |
141,000
+128,700
| +1,046% | +$5.06M | 0.01% | 1311 |
|
|
2020
Q4 | $84K | Buy |
12,300
+1,300
| +12% | +$11.6K | ﹤0.01% | 4683 |
|
|
2020
Q3 | $127K | Sell |
11,000
-7,100
| -39% | -$32K | ﹤0.01% | 4022 |
|
|
2020
Q2 | $56K | Buy |
18,100
+12,400
| +218% | +$56.2K | ﹤0.01% | 4277 |
|
|
2020
Q1 | $23K | Buy |
+5,700
| New | +$37.7K | ﹤0.01% | 4162 |
|
|
2014
Q4 | – | Sell |
-86
| Closed | -$2K | – | 5225 |
|
|
2014
Q3 | $2K | Sell |
86
-43
| -33% | -$1.31K | ﹤0.01% | 4938 |
|
|
2014
Q2 | $5K | Sell |
129
-957
| -88% | -$35.4K | ﹤0.01% | 4765 |
|
|
2014
Q1 | $42K | Buy |
1,086
+915
| +535% | +$32.3K | ﹤0.01% | 3752 |
|
|
2013
Q4 | $6K | Sell |
171
-458
| -73% | -$12.2K | ﹤0.01% | 4799 |
|
|
2013
Q3 | $12K | Buy |
629
+129
| +26% | +$2.25K | ﹤0.01% | 4421 |
|
|
2013
Q2 | $8K | Buy |
+500
| New | +$10.6K | ﹤0.01% | 4524 |
|
Other funds holding FLNA
VCM
GC
Group One Trading's FLNA Position: Q1 2026 in Review
Group One Trading increased its Filana Therapeutics (FLNA) stake by 12% in Q1 2026, buying an estimated $68.3K and bringing the position to 302,624 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #3324.
Group One Trading first reported a position in FLNA in Q3 2013 and has held it in 34 quarters since. The position peaked at $46.5M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Group One Trading held 302,624 shares of Filana Therapeutics worth $511K as of Q1 2026.
- Group One Trading bought 33,154 Filana Therapeutics shares in Q1 2026, an estimated $68.3K.
- Filana Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3324 holding.
- Group One Trading first reported a position in Filana Therapeutics in Q3 2013 and has held it in 34 quarters since.
- Group One Trading's Filana Therapeutics position peaked at $46.5M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.